A study published in April in the Journal of the American Cancer Society (ACS) found that taking daily low-dose aspirin may reduce the incidence and death rates of colorectal cancer. In contrast, a large 2020 clinical trial called ASPREE, published in the Journal of the Natural Cancer Institute, suggested that aspirin increases the cancer incidence and death rate in older adults.
Does this mean that aspirin helps some age groups with cancer but not others? The short answer: possibly.
